Supernus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
CEOJack A. Khattar
CEOJack A. Khattar
Employees674
Employees674
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2005
Founded2005
Employees674
Employees674
SUPN Key Statistics
Market cap1.87B
Market cap1.87B
Price-Earnings ratio30.27
Price-Earnings ratio30.27
Dividend yield—
Dividend yield—
Average volume519.32K
Average volume519.32K
High today$33.72
High today$33.72
Low today$32.34
Low today$32.34
Open price$32.47
Open price$32.47
Volume531.65K
Volume531.65K
52 Week high$40.28
52 Week high$40.28
52 Week low$25.53
52 Week low$25.53
SUPN News
Simply Wall St 6d
Shareholders Can Be Confident That Supernus Pharmaceuticals' Earnings Are High QualitySupernus Pharmaceuticals, Inc. ( ) just reported healthy earnings but the stock price didn't move much. Investors are probably missing some underlying factors w...
People also own
Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.